BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 31906738)

  • 1. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

  • 2. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
    Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
    D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
    Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
    Pin Vieito N; Zarraquiños S; Cubiella J
    World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
    BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of advanced colorectal neoplasia and relative colonoscopy workloads using quantitative faecal immunochemical tests: an observational study exploring the effects of simultaneous adjustment of both sample number and test positivity threshold.
    Young GP; Woodman RJ; Symonds E
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32994195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.
    D'Souza N; Hicks G; Benton SC; Abulafi M
    Ann R Coll Surg Engl; 2020 Mar; 102(3):174-179. PubMed ID: 31697171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
    Senore C; Zappa M; Campari C; Crotta S; Armaroli P; Arrigoni A; Cassoni P; Colla R; Fracchia M; Gili F; Grazzini G; Lolli R; Menozzi P; Orione L; Polizzi S; Rapi S; Riggi E; Rubeca T; Sassatelli R; Visioli C; Segnan N
    Gut; 2020 Mar; 69(3):523-530. PubMed ID: 31455608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway.
    Johnstone MS; Burton P; Kourounis G; Winter J; Crighton E; Mansouri D; Witherspoon P; Smith K; McSorley ST
    Int J Colorectal Dis; 2022 Feb; 37(2):457-466. PubMed ID: 34932152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
    van Turenhout ST; Oort FA; van der Hulst RW; Visscher AP; Terhaar sive Droste JS; Scholten P; Bouman AA; Meijer GA; Mulder CJ; van Rossum LG; Coupé VM
    BMC Gastroenterol; 2014 Dec; 14():217. PubMed ID: 25528043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
    Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
    Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
    Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
    [No Abstract]   [Full Text] [Related]  

  • 18. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
    Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
    Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
    Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
    United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients.
    D'Souza N; Monahan K; Benton SC; Wilde L; Abulafi M;
    Colorectal Dis; 2021 Oct; 23(10):2539-2549. PubMed ID: 34240526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.